Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
about
Pentoxifylline in amphotericin B toxicity rat modelAn Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased SafetyAspergillus fumigatus and aspergillosisPentoxifylline modulates activation of human neutrophils by amphotericin B in vitro.Influence of the freeze-drying process on the physicochemical and biological properties of pre-heated amphotericin B micellar systemsAmphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycosesThe endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B.Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability.Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments.Differential effects of paromomycin on ribosomes of Leishmania mexicana and mammalian cellsThe production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug.Amphotericin B protects cis-parinaric acid against peroxyl radical-induced oxidation: amphotericin B as an antioxidantAmphotericin B: current understanding of mechanisms of action.Interference with effects of amphotericin B on Candida albicans cells by 2-chloroethyl-1-nitrosoureas.Carrier effects on biological activity of amphotericin B.In vitro models for studying toxicity of antifungal agentsComparative antibacterial activity of Vancocin and generic vancomycin.Effect of Candida morphology on amphotericin B susceptibility.Sensitivity of Candida albicans to amphotericin B administered as single or fractionated dosesLate treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals.Optimizing efficacy of amphotericin B through nanomodification.Toxicity and induction of resistance to Listeria monocytogenes infection by amphotericin B in inbred strains of miceSupplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B.Optimizing efficacy of Amphotericin B through nanomodification.Probing the biology of natural products: molecular editing by diverted total synthesis.Complexation of amphotericin B and curcumin with serum albumins: solubility and effect on erythrocyte membrane damage.Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.Failure of aminoglycoside antibiotics to kill anaerobic, low-pH, and resistant cultures.Heat-induced superaggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index.Synergistic fungicidal activities of amphotericin B and N-methyl-N"-dodecylguanidine: a constituent of polyol macrolide antibiotic niphimycin.Enhancement of macrophage superoxide anion production by amphotericin B.Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.Quercetin and rutin as potential agents antifungal against Cryptococcus spp.Phagomimetic action of antimicrobial agents.Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane.
P2860
Q28334674-AAB50C8E-2F35-4ED2-811C-5F010613C388Q28554384-85098CC6-DE88-4C22-BFF8-B7CA3F6AD243Q29617908-2C184433-0EF0-4E47-B3F5-420D8C9C65FCQ30311275-70387345-8434-4CEF-B23E-669D49A4176AQ33681274-1DCAA5D4-1945-4BB5-839F-144F86F753C7Q33749120-3DFE99C5-ADA9-4B61-89BC-D3BE2EC53BC3Q33761253-95950245-789A-4F6B-B08E-A7C61523F082Q34294886-B224B8C0-874F-4386-ABB6-9815C53757DDQ34417313-4560758C-2FBA-4DF1-BA52-B13134CFFA31Q34483607-932E9CB5-350F-4D3F-B1D0-8E85B00F312AQ34596780-0E7F26E2-13C5-4310-A140-362ED9BEAB5BQ35134662-869E3F9C-F5A4-4AC8-B241-1368ECD4CD9AQ35247730-C6325E45-1071-47B9-BB29-F477620D8B22Q35294618-C2381E62-BD6F-428F-9ED0-0FDE5840FE90Q35372581-1A7E7CB4-FC27-43DE-BAF4-A25AF38D88ECQ35447528-14D7BA64-F5D4-459C-AFE0-F5BF945CC4E4Q35537147-4B43A788-7A9D-47C1-90F9-957DE873ABFBQ35537177-6F130C2D-B1F6-4086-A1AB-23CEEEEC5966Q35649977-6ACBE3F3-613D-413A-950D-8ADFF24C40F6Q36549164-04F3BDF5-04CE-4954-9B63-0505ABB91CDEQ36920328-FDF25A38-E217-4ECA-8B8B-016D84B6531BQ37012651-FAFCC5ED-849F-455B-A0F3-61CDB09B1E46Q37033956-D60706C0-272E-439F-8AB7-5746808C3BF9Q37178176-57BE3060-140C-4468-B729-C3086A8A9137Q37809500-5C6416F6-471D-4F85-9EBA-9F1450AC2B6DQ38836051-F8F2981F-B1F4-4012-B491-D294A714EDE3Q38967744-8820B1BE-8DAF-4607-915D-785DD98F1D38Q39548862-012577D6-9205-484A-BAEE-B4153B899C05Q39785217-CD6871DA-28EC-463B-B1AA-10E681C1ABC9Q39791620-7795A96A-7199-4EEF-95D6-C68048B889AFQ40086453-6F1ABEA4-34C7-473F-A66B-3C17140EC2CEQ40284723-468AE9ED-38B5-4796-AB83-0EE34CDAB1D6Q40679576-07FB341F-BB51-48DF-ACDA-6334736D7D98Q41746005-88CFE745-5AA4-44AB-870C-626DE9363DBEQ46828205-6173EE72-1C56-4A08-8CDE-9E9AD167C714
P2860
Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
@ast
Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
@en
type
label
Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
@ast
Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
@en
prefLabel
Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
@ast
Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
@en
P2093
P2860
P356
P1476
Involvement of oxidative damage in erythrocyte lysis induced by amphotericin B.
@en
P2093
A Vertut-Croquin
D R Schwartz
D Schlessinger
G S Kobayashi
J Brajtburg
P2860
P304
P356
10.1128/AAC.27.2.172
P407
P577
1985-02-01T00:00:00Z